Abstract
Background
Colorectal cancer is one of the leading causes of cancer-associated morbidity and mortality worldwide. The local anti-tumour immune response is particularly important for patients with stage II where the tumour-draining lymph nodes have not yet succumbed to tumour spread. The lymph nodes allow for the expansion and release of B cell compartments such as primary follicles and germinal centres. A variation in this anti-tumour immune response may influence the observed clinical heterogeneity in stage II patients.
Aim
The aim of this study was to explore tumour-draining lymph node histomorphological changes and tumour pathological risk factors including the immunomodulatory microRNA-21 (miR-21) in a small cohort of stage II CRC.
Methods
A total of 23 stage II colorectal cancer patients were included. Tumour and normal mucosa samples were analysed for miR-21 expression levels and B-cell compartments were quantified from Haematoxylin and Eosin slides of lymph nodes. These measures were compared to clinicopathological risk factors such as perforation, bowel obstruction, T4 stage and high-grade.
Results
We observed greater Follicle density in patients with a lower tumour T stage and higher germinal centre density in patients with higher pre-operative carcinoembryonic antigen levels. Trends were also detected between tumours with deficiency in mismatch repair proteins, lymphatic invasion and both the density and size of B-cell compartments. Lastly, elevated tumour miR-21 was associated with decreased Follicle and germinal centre size.
Conclusion
Variation in B-cell compartments of tumour-draining lymph nodes is associated with clinicopathological risk factors in stage II CRC patients.
Publisher
Public Library of Science (PLoS)
Reference24 articles.
1. NCCN Clinical Practice Guidelines in Oncology Colon Cancer 2.2018: National Comprehensive Cancer Network. Available at https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed 30 November 2018.
2. Adjuvant Chemotherapy Is Associated With Improved Survival in Patients With Stage II Colon Cancer;L Casadaban;Cancer,2016
3. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features;E O’Connor;Journal of Clinical Oncology,2011
4. Path Toward Prognostication and Prediction: An Evolving Matrix;AB Benson;Journal of Clinical Oncology,2011
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献